Clearside Biomedical, Inc. (CLSD) Total Assets by Year
Clearside Biomedical, Inc. closed fiscal year 2024 with $25.1M in total assets, $64.0M in total liabilities and -$38.9M in shareholder equity. This represents a decrease of 26.1% from the prior fiscal year. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Clearside Biomedical, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CLSD Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.1M-26.1% | $34.0M-33.7% | $51.3M+19.6% | $42.9M+122.0% | $19.3M-27.8% | $26.8M-39.3% | $44.1M+9.0% | $40.5M-52.3% | $84.8M+302.8% | $21.1M | N/A |
| Total Liabilities | $64.0M+28.1% | $49.9M+22.7% | $40.7M+725.8% | $4.9M-53.3% | $10.6M-32.4% | $15.6M-23.8% | $20.5M+7.5% | $19.1M+45.0% | $13.2M-77.2% | $57.7M | N/A |
| Total Equity | -$38.9M-144.2% | -$15.9M-250.0% | $10.6M-72.1% | $38.0M+333.4% | $8.8M-21.5% | $11.2M-52.8% | $23.6M+10.3% | $21.4M-70.1% | $71.7M+295.5% | -$36.7M-90.8% | -$19.2M |
CLSD Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'25 | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.6M-60.1% | $15.3M-54.8% | $19.7M-51.0% | $25.1M-26.1% | $29.2M-15.3% | $33.9M-13.4% | $40.1M-10.2% | $34.0M-33.7% | $34.4M-38.2% | $39.2M+27.4% | $44.7M+23.9% | $51.3M+19.6% |
| Total Liabilities | $65.6M+2.6% | $64.1M+3.0% | $65.6M+5.9% | $64.0M+28.1% | $64.0M+35.3% | $62.2M+40.9% | $62.0M+47.5% | $49.9M+22.7% | $47.3M+27.3% | $44.2M+703.2% | $42.0M+864.1% | $40.7M+725.8% |
| Total Equity | -$54.0M-55.1% | -$48.7M-72.3% | -$45.9M-110.5% | -$38.9M-144.2% | -$34.8M-170.8% | -$28.3M-468.8% | -$21.8M-907.8% | -$15.9M-250.0% | -$12.8M-169.3% | -$5.0M-119.7% | $2.7M-91.5% | $10.6M-72.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Clearside Biomedical, Inc. financials
Frequently Asked Questions
What was Clearside Biomedical, Inc.'s total assets in fiscal year 2024?
Clearside Biomedical, Inc. closed fiscal year 2024 with $25.1M in total assets, $64.0M in total liabilities and -$38.9M in shareholder equity.
How fast is Clearside Biomedical, Inc.'s total assets growing?
Clearside Biomedical, Inc. (CLSD) total assets fell by 26.1% year over year, from $34.0M to $25.1M in fiscal year 2024.
What was Clearside Biomedical, Inc.'s total assets in the most recent quarter?
Clearside Biomedical, Inc. (CLSD) reported $11.6M in total assets in Q3 2025. This represents a decrease of 60.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Clearside Biomedical, Inc. (CLSD) reported on that line in every period on record.